申请人:SS PHARMACEUTICAL CO., LTD.
公开号:EP0498372A1
公开(公告)日:1992-08-12
A sustained-release pranoprofen preparation is disclosed. The preparation comprises an effective amount of pranoprofen and one or more sustained-release components selected from the group consisting of oily components, water-soluble components, water-insoluble components, and intestinally soluble components. It controls release of pranoprofen and lowers the maximum pranoprofen concentration in blood, maintaining its concentration in blood at a certain level for a long period of time. It reduces risks of side effects and can effectively treat diseases with dosing once or twice a day.
本发明公开了一种普拉洛芬缓释制剂。该制剂由有效量的普拉洛芬和一种或多种缓释成分组成,这些缓释成分选自油性成分、水溶性成分、水不溶性成分和肠溶性成分组成的组。它能控制普拉洛芬的释放,降低血液中普拉洛芬的最高浓度,使血液中的浓度长期保持在一定水平。它能降低副作用的风险,每天用药一到两次,就能有效治疗疾病。